000 | 01258 a2200337 4500 | ||
---|---|---|---|
005 | 20250514181931.0 | ||
264 | 0 | _c20040707 | |
008 | 200407s 0 0 eng d | ||
022 | _a0378-584X | ||
024 | 7 |
_a10.1159/000075600 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSutter, A P | |
245 | 0 | 0 |
_aRecent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer. _h[electronic resource] |
260 |
_bOnkologie _cFeb 2004 |
||
300 |
_a17-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aCell Transformation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aEsophageal Neoplasms _xblood supply |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aZeitz, M | |
700 | 1 | _aScherĂ¼bl, H | |
773 | 0 |
_tOnkologie _gvol. 27 _gno. 1 _gp. 17-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000075600 _zAvailable from publisher's website |
999 |
_c14727256 _d14727256 |